Rewards on the road less traveled

Article Abstract:

A profile of Pharmaxis, an Australian pharmaceutical company that intends to commercialize its products, is presented. Conventional Australian pharmaceutical companies tend to sell their medical discoveries, book short-term profits and please investors. An analysis of Pharmaxis's financial performance, and stock prices, is presented for the benefit of investors.

Product development, Pharmaceutical preparations, Securities issued, listed, Pharmaceutical industry, Finance, Securities, Company securities, Company financing

---

Mixed messages

Article Abstract:

Reports are evaluated about inventory of stocks and the development rate in different companies. It is observed that, growth rate of company is at easement while profits are growing. Guidance rate is minute in the growth of a company. Investors are happy on even moderately negative comments and for companies who go against, share prices will suffer.

Venture Analysis, Economic aspects, Business enterprises, Growth, Investor relations, Company growth

---

Between the lines

Article Abstract:

A forecast and the trends in invetments for the television production industry in Australia are presented.

Forecasts, trends, outlooks, Motion picture & video production, Company investment, Investments, Television production companies, Industry forecasts

Similar abstracts:

• Abstracts: Sugar hits the spot. Growers spared the cane. Spoonful of trouble
• Abstracts: The new learning curve. Execute the learning agenda. Strange bedfellows
• Abstracts: Rules of engagement. The duty trap. Opportunity lost

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.